Nathan Fowler
The University of Texas MD Anderson Cancer Center(US)Addgene(US)Boston Engineering (United States)(US)Baker Hughes (United Kingdom)(GB)Repligen (United States)(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Conserved pan-cancer microenvironment subtypes predict response to immunotherapy(2021)1,250 cited
- → Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies(2012)1,110 cited
- → Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma(2015)1,102 cited
- → Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas(2020)570 cited
- → Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial(2013)529 cited
- → Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial(2021)500 cited